Clinical Trials Browser

Interventional × Breast Neoplasms, Male × Epirubicin × Clear all

NCT00301925 2018-08-08

TACT2

Phase 3 Unknown

Breast Neoplasms, Breast Neoplasms, Male

NCT01624441 2018-03-30

Dinaciclib and Epirubicin Hydrochloride in Treating Patients With Metastatic Triple-Negative Breast Cancer

Phase 1 Completed

Breast Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms

NCT00176488 2017-03-23

Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer

Phase 2 Terminated

31 enrolled 6 charts

Breast Neoplasms, Breast Neoplasms, Male